文献速递膀胱癌与上尿路尿路上皮癌

FDG-PET-CT完全代谢缓解预测淋巴结阳性膀胱癌诱导化疗后根治性膀胱切除术的生存

Complete metabolic response with [18 F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer.
PubMed 文献 · BJU Int · 2021-04-23

本研究纳入86例临床淋巴结阳性膀胱癌患者,在顺铂为基础的诱导化疗期间重复FDG-PET-CT,其中71例化疗有反应者行根治性膀胱切除术。通过SUVmax、 adapted Deauville标准及TLG三种方法评估淋巴结代谢反应,多变量Cox回归显示完全缓解与无进展生存和癌症特异性生存改善相关。

要点

  • FDG-PET-CT完全代谢缓解可预测淋巴结阳性膀胱癌诱导化疗后根治性膀胱切除术的生存改善。
  • SUVmax和adapted Deauville标准评估的完全缓解与PFS(HR 3.42)和CSS(HR 3.30)改善相关。
  • TLG评估的完全缓解同样与PFS(HR 5.17)和CSS(HR 6.32)改善相关。

核心结论

  • FDG-PET-CT完全代谢缓解可预测淋巴结阳性膀胱癌患者诱导化疗后根治性膀胱切除术的生存。

研究设计与样本

  • 2007至2018年纳入86例临床淋巴结阳性膀胱癌(T1-T4,N1-N3,M0-M1a)患者,化疗期间重复FDG-PET-CT,71例化疗有反应者行根治性膀胱切除术。

主要发现

  • 中位随访40个月,71例行根治性膀胱切除术的患者中15例死于膀胱癌。
  • SUVmax和adapted Deauville标准评估的完全缓解与PFS改善相关(HR 3.42,95%CI 1.20-9.77)及CSS改善相关(HR 3.30,95%CI 1.02-10.65)。
  • TLG评估的完全缓解与PFS改善相关(HR 5.17,95%CI 1.90-14.04)及CSS改善相关(HR 6.32,95%CI 2.06-19.41)。

关键数值与推荐

  • 完全代谢缓解通过三种方法评估:SUVmax、adapted Deauville标准及总病灶糖酵解(TLG)。
  • 多变量Cox回归分析调整年龄、临床肿瘤分期和淋巴结分期。

临床怎么用

  • FDG-PET-CT完全代谢缓解可作为术前评估化疗反应的工具,识别显著缓解者以完成全疗程诱导化疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether repeated [18 F]fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET-CT) scans can predict increased cancer-specific survival (CSS) after induction chemotherapy followed by radical cystectomy (RC). PATIENTS AND METHODS: Between 2007 and 2018, 86 patients with clinically lymph node (LN)-positive bladder cancer (T1-T4, N1-N3, M0-M1a) were included and underwent a repeated FDG-PET-CT during cisplatin-based induction chemotherapy. The 71 patients that had a response to chemotherapy underwent RC. Response to chemotherapy was evaluated in LNs through repeated FDG-PET-CT and stratified as partial response or complete response using three different methods: maximum standardised uptake value (SUVmax ), adapted Deauville criteria, and total lesion glycolysis (TLG). Progression-free survival (PFS) and CSS were analysed for all three methods by Cox regression analysis. RESULTS: After a median follow-up of 40 months, 15 of the 71 patients who underwent RC had died from bladder cancer. Using SUVmax and the adapted Deauville criteria, multivariable Cox regression analyses adjusting for age, clinical tumour stage and LN stage showed that complete response was associated with increased PFS (hazard ratio [HR] 3.42, 95% confidence interval [CI] 1.20-9.77) and CSS (HR 3.30, 95% CI 1.02-10.65). Using TLG, a complete response was also associated with increased PFS (HR 5.17, 95% CI 1.90-14.04) and CSS (HR 6.32, 95% CI 2.06-19.41). CONCLUSIONS: Complete metabolic response with FDG-PET-CT predicts survival after induction chemotherapy followed by RC in patients with LN-positive bladder cancer and comprises a novel tool in evaluating response to chemotherapy before surgery. This strategy has the potential to tailor treatment in individual patients by identifying significant response to chemotherapy, which motivates the administration of a full course of induction chemotherapy with a higher threshold for suspending treatment due to toxicity and side-effects.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Abrahamsson J, Kollberg P, Almquist H, et al. Complete metabolic response with [18 F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer. BJU Int. 2021. PMID: 33626220. doi:10.1111/bju.15374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。